Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abeona, Angion, Athera, Constant, Eikonizo, Invectys, Moderna, Nextcure, Palatin, PTC, Regenxbio, Ridgeback, Vaccinex, Ziopharm.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 4D Pharma, Abivax, Biontech, CSL Behring, Daiichi Sankyo, Depuy Synthes Products, Durect, Inovio, Oncolys, Orthocell, Pfizer, Regeneron, Sanofi, Timber, Transcenta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cerus, Myriad, Natera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Annovis, Apellis, Cohbar, Corvus, Curis, Cyteir, Entera, Evive, Lipidor, Inmed, Novocure, Onconova, Otonomy, Outlook, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Adverum, Avrobio, Anavex, Bellus, Celixir, CSL, Deciphera, Gensight, Gilead, Idorsia, Immunomedics, Inventiva, Merck, Myovant, Obseva, Oryzon, Sunovion, Regeneron, Sanofi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Berlin Heart, Osteolabs, Pulse Biosciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abivax, Apellis, Biocardia, Menarini, Moleculin, Pfizer, Vaccibody.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Biomodex, Elucid Bio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Anavex, Biondvax, Biontech, Context, Corcept, Daiichi, Durect, Eyenovia, Ipsen, Matinas, Oncolys, Pfizer, Polypid, Revance, Timber, Vasopharm.